vorinostat has been researched along with Endometrial Diseases in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchida, H | 1 |
| Maruyama, T | 1 |
| Nagashima, T | 1 |
| Ono, M | 1 |
| Masuda, H | 1 |
| Arase, T | 1 |
| Sugiura, I | 1 |
| Onouchi, M | 1 |
| Kajitani, T | 1 |
| Asada, H | 1 |
| Yoshimura, Y | 1 |
1 review available for vorinostat and Endometrial Diseases
| Article | Year |
|---|---|
Human endometrial cytodifferentiation by histone deacetylase inhibitors.
Topics: Acetylation; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Movement; Endometri | 2006 |